Has medical innovation reduced cancer mortality?

Frank Lichtenberg

No 15880, NBER Working Papers from National Bureau of Economic Research, Inc

Abstract: I analyze the effects of four types of medical innovation and cancer incidence on U.S. cancer mortality rates during the period 2000-2009, by estimating difference-in-differences models using longitudinal (annual) data on about 60 cancer sites (breast, colon, etc.). The outcome measure used is not subject to lead-time bias. I control for mean age at diagnosis, the stage distribution of patients at time of diagnosis, and the sex and race of diagnosed patients. Under the assumption that there were no pre‐dated factors that drove both innovation and mortality and that there would have been parallel trends in mortality in the absence of innovation, the estimates indicate that there were three major sources of the 13.8% decline of the age-adjusted cancer mortality rate during 2000-2009. Drug innovation and imaging innovation are estimated to have reduced the cancer mortality rate by 8.0% and 4.0%, respectively. The decline in incidence is estimated to have reduced the cancer mortality rate by 1.2%. The social value of the reductions in cancer mortality attributable to medical innovations has been enormous, and much greater than the cost of these innovations.

JEL-codes: C23 C33 I12 J1 L64 L65 O33 (search for similar items in EconPapers)
Date: 2010-04
New Economics Papers: this item is included in nep-hea and nep-ino
Note: EH PR
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (6)

Published as “Has Medical Innovation Reduced Cancer Mortality?,” CESifo Economic Studies, published online 14 November 2013.

Downloads: (external link)
http://www.nber.org/papers/w15880.pdf (application/pdf)

Related works:
Journal Article: Has Medical Innovation Reduced Cancer Mortality? (2014)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:15880

Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w15880

Access Statistics for this paper

More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().